These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9580841)

  • 41. [Abuse of anabolic-androgenic steroids in sports].
    Lise ML; da Gama e Silva TS; Ferigolo M; Barros HM
    Rev Assoc Med Bras (1992); 1999; 45(4):364-70. PubMed ID: 10752246
    [No Abstract]   [Full Text] [Related]  

  • 42. Medical aspects of drug use in the gym.
    Drug Ther Bull; 2004 Jan; 42(1):1-5. PubMed ID: 14768297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids.
    Smith DA; Perry PJ
    Ann Pharmacother; 1992 Apr; 26(4):520-8. PubMed ID: 1533554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. American College of Sports Medicine position stand on the use of anabolic-androgenic steroids in sports.
    Med Sci Sports Exerc; 1987 Oct; 19(5):534-9. PubMed ID: 3316907
    [No Abstract]   [Full Text] [Related]  

  • 45. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of androgenic and anabolic steroids on the sebaceous gland in power athletes.
    Király CL; Alén M; Rahkila P; Horsmanheimo M
    Acta Derm Venereol; 1987; 67(1):36-40. PubMed ID: 2436412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linear keloids resulting from abuse of anabolic androgenic steroid drugs.
    Scott MJ; Scott MJ; Scott AM
    Cutis; 1994 Jan; 53(1):41-3. PubMed ID: 8119077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The use of drugs to improve athletic performance].
    Kuipers H; Hartgens F
    Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current concepts in anabolic-androgenic steroids.
    Evans NA
    Am J Sports Med; 2004 Mar; 32(2):534-42. PubMed ID: 14977687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anabolic steroids.
    Strauss RH
    Clin Sports Med; 1984 Jul; 3(3):743-8. PubMed ID: 6443757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anabolic androgenic steroids (AAS) as doping agents: chemical structures, metabolism, cellular responses, physiological and pathological effects.
    Fineschi V
    Mini Rev Med Chem; 2011 May; 11(5):359-61. PubMed ID: 21443515
    [No Abstract]   [Full Text] [Related]  

  • 52. Anabolic steroids: a review for the clinician.
    Kutscher EC; Lund BC; Perry PJ
    Sports Med; 2002; 32(5):285-96. PubMed ID: 11929356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgen-androgenic steroids, the athlete, and mortality.
    Cotlar MJ
    J Insur Med; 2001; 33(3):251-6. PubMed ID: 11558405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ergogenic aids: a review of basic science, performance, side effects, and status in sports.
    Tokish JM; Kocher MS; Hawkins RJ
    Am J Sports Med; 2004 Sep; 32(6):1543-53. PubMed ID: 15310585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping.
    Solimini R; Rotolo MC; Mastrobattista L; Mortali C; Minutillo A; Pichini S; Pacifici R; Palmi I
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):7-16. PubMed ID: 28379599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aortic elastic properties in athletes using anabolic-androgenic steroids.
    Kasikcioglu E; Oflaz H; Arslan A; Topcu B; Kasikcioglu HA; Umman B; Bugra Z; Kayserilioglu A
    Int J Cardiol; 2007 Jan; 114(1):132-4. PubMed ID: 16364476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Supplement use in the adolescent athlete.
    DesJardins M
    Curr Sports Med Rep; 2002 Dec; 1(6):369-73. PubMed ID: 12831686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?
    Rogol AD
    Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
    Curry LA; Wagman DF
    Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse effects of anabolic steroids in athletes. A constant threat.
    Maravelias C; Dona A; Stefanidou M; Spiliopoulou C
    Toxicol Lett; 2005 Sep; 158(3):167-75. PubMed ID: 16005168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.